Korean Circulation Journal, 2019 Background and Objectives Wrist-worn wearable devices provide heart rate (HR) monitoring function via photoplethysmography technology. Recently, these devices have been used by patients to measure the HR when palpitation occurs, but few validation ...
Jongmin Hwang +5 more
semanticscholar +1 more source
PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES) [PDF]
Acta Medica Iranica, 1986 Propafenone HCI (p), is a relatively new Class IC antiarrhythmic agent. It has been reported to be superior to conventional antiarrhythmics in the control of supraventricular, ventricular and WPW associated tachyarrhythmias.
IRAJ NAZERY +1 more
doaj +1 more source
Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2018 Background Contemporary data about symptomatic paroxysmal supraventricular tachycardia (PSVT) epidemiology are limited. We characterized prevalence and correlates of symptomatic PSVT within a large healthcare delivery system and estimated national PSVT ...
A. Go +6 more
semanticscholar +1 more source
Fetal Tachyarrhythmia - Part I: Diagnosis [PDF]
, 2004 Fetal tachycardia, first recognized in 1930 by Hyman et al1, is a condition occurring in approximately 0.4-0.6% of all pregnancies2. A subset of these cases with more sustained periods of tachycardia is clinically relevant.
Meijboom, Erik J +2 more
core +39 more sources
Zero‐fluoroscopy ablation for cardiac arrhythmias: A single‐center experience in Japan
Journal of Arrhythmia, 2021 Background Exposure to radiation during catheter ablation procedures poses a risk to the heath of both the patient and electrophysiology laboratory staff.
Tohru Kawakami +14 more
doaj +1 more source
Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia [PDF]
, 2015 Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a difficult-to-diagnose cause of sudden cardiac death (SCD). We identified a family of 1400 individuals with multiple cases of CPVT, including 36 SCDs during youth.
Allegue, Catarina +12 more
core +2 more sources
Antiarrhythmic and proarrhythmic effects of subcutaneous nerve stimulation in ambulatory dogs [PDF]
, 2019 Background High output subcutaneous nerve stimulation (ScNS) remodels the stellate ganglia and suppresses cardiac arrhythmia. Objective To test the hypothesis that long duration low output ScNS causes cardiac nerve sprouting, increases plasma ...
Chen, Mu +10 more
core +1 more source
Analysis of short-term blood pressure variability in pheochromocytoma/paraganglioma patients [PDF]
, 2019 Data on short-term blood pressure variability (BPV), which is a well-established cardiovascular prognostic tool, in pheochromocytoma and paraganglioma (PPGL) patients is still lack and conflicting.
Bisogni, V. +14 more
core +1 more source
PAROXYSMAL TACHYCARDIA IN CHILDHOOD [PDF]
Archives of Pediatrics & Adolescent Medicine, 1917 The function of originating and transmitting the automatic impulses which result in the contraction of the heart belongs to certain specialized tissues which represent the remnant of the primitive cardiac tube. These excitation waves have been shown to arise at the junction of the superior vena cava with the right auricle, in the upper portion of the ...
openaire +3 more sources
Cisplatin induced paroxysmal supraventricular tachycardia
Indian Journal of Medical and Paediatric Oncology, 2013 Cisplatin or cis-diamminedichloroplatinum (CDDP) is the first member of a class of platinum-containing anti-cancer drugs that act by binding to and causing cross-linking of deoxyribonucleic acid, which ultimately triggers apoptosis. Cisplatin has a broad-
Waseem Raja +4 more
doaj +1 more source